FindMyKOL
Clinical trialNCT00017082CompletedPhase 2Interventional

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

SponsorPrologue Research InternationalColorectal Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have recurrent metastatic colorectal cancer.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Washington Cancer Institute

    Washington D.C., District of Columbia, United States

  • Comprehensive Cancer Care Specialists of Boca Raton

    Boca Raton, Florida, United States

  • Kentuckiana Cancer Institute

    Louisville, Kentucky, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

  • Veterans Affairs Medical Center - Albany

    Albany, New York, United States

  • Southeastern Medical Oncology Center

    Goldsboro, North Carolina, United States

  • Raleigh Hematology/oncology Associates - Wake Practice

    Raleigh, North Carolina, United States

  • Pinnacle Health Hospitals

    Harrisburg, Pennsylvania, United States

  • University of Pennsylvania Cancer Center

    Philadelphia, Pennsylvania, United States

  • Memphis Cancer Center

    Memphis, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Oxaliplatin →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2001
Primary completion
30 Jun 2003
Completion
31 Dec 2010
Last update posted
26 Jun 2013
Registered enrollment
—
Registry id
NCT00017082
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.